Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 16/20 | 0.72 |
| ▸ | LONP1 | P36776 | 11/20 | 0.72 |
| ▸ | PSMB8 | P28062 | 11/20 | 0.72 |
| ▸ | PSMB9 | P28065 | 11/20 | 0.72 |
| ▸ | PSMB6 | P28072 | 11/20 | 0.72 |
| ▸ | PSMB10 | P40306 | 11/20 | 0.72 |
| ▸ | PSMB11 | A5LHX3 | 10/20 | 0.72 |
| ▸ | PSMA7 | O14818 | 10/20 | 0.72 |
| ▸ | PSMB1 | P20618 | 10/20 | 0.72 |
| ▸ | PSMA1 | P25786 | 10/20 | 0.72 |
| ▸ | PSMA2 | P25787 | 10/20 | 0.72 |
| ▸ | PSMA3 | P25788 | 10/20 | 0.72 |
| ▸ | PSMA4 | P25789 | 10/20 | 0.72 |
| ▸ | PSMA5 | P28066 | 10/20 | 0.72 |
| ▸ | PSMB4 | P28070 | 10/20 | 0.72 |
| ▸ | PSMB3 | P49720 | 10/20 | 0.72 |
| ▸ | PSMB2 | P49721 | 10/20 | 0.72 |
| ▸ | PSMA6 | P60900 | 10/20 | 0.72 |
| ▸ | PSMA8 | Q8TAA3 | 10/20 | 0.72 |
| ▸ | PSMB7 | Q99436 | 10/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2125721 | 0.99 | PSMB5 (0.71) | PSMB5LONP1PSMB8PSMB9PSMB6 | |
| SCHEMBL2126548 | 0.99 | PSMB5 (0.71) | PSMB5LONP1PSMB8PSMB9PSMB6 | |
| SCHEMBL2125752 | 0.97 | PSMB5 (0.76) | PSMB5LONP1PSMB8PSMB9PSMB6 | |
| SCHEMBL1913443 | 0.97 | PSMB5 (0.76) | PSMB5LONP1PSMB8PSMB9PSMB6 | |
| SCHEMBL2126012 | 0.95 | PSMB5 (0.67) | PSMB5LONP1PSMB8PSMB9PSMB6 | |
| SCHEMBL2125411 | 0.95 | PSMB5 (0.67) | PSMB5LONP1PSMB8PSMB9PSMB6 | |
| SCHEMBL2127762 | 0.93 | PSMB5 (0.73) | PSMB5LONP1PSMB8PSMB9PSMB6 | |
| SCHEMBL2125581 | 0.90 | LONP1 (0.59) | PSMB5LONP1PSMB8PSMB9PSMB6 | |
| SCHEMBL12521571 | 0.89 | PSMB5 (0.74) | PSMB5LONP1PSMB8PSMB9PSMB6 | |
| SCHEMBL2128981 | 0.88 | LONP1 (0.58) | PSMB5LONP1PSMB8PSMB9PSMB6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120135921-A1 | TRIPETIDE BORONIC ACID OR BORONIC ESTER, PREPARATIVE METHOD AND USE THEREOF | PEKING UNIVERSITY (CN) | 2012-05-31 | — | — | US | claimed |
| EP-2444411-A1 | TRIPEPTIDE BORONIC ACID OR BORONIC ESTER, PREPARATIVE METHOD AND USE THEREOF | Peking University (CN) | 2012-04-25 | — | — | EP | claimed |
| EP-2444411-B1 | TRIPEPTIDE BORONIC ACID OR BORONIC ESTER, PREPARATIVE METHOD AND USE THEREOF | UNIV BEIJING (CN) | 2016-10-26 | — | — | EP | disclosed |
| US-9421237-B2 | Tripeptide boronic acid or boronic ester, preparative method and use thereof | PEKING UNIVERSITY (CN) | 2016-08-23 | — | — | US | disclosed |
| US-20120135921-A1 | TRIPETIDE BORONIC ACID OR BORONIC ESTER, PREPARATIVE METHOD AND USE THEREOF | PEKING UNIVERSITY (CN) | 2012-05-31 | — | — | US | disclosed |
| EP-2444411-A1 | TRIPEPTIDE BORONIC ACID OR BORONIC ESTER, PREPARATIVE METHOD AND USE THEREOF | Peking University (CN) | 2012-04-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135921-A1 | TRIPETIDE BORONIC ACID OR BORONIC ESTER, PREPARATIVE METHOD AND USE THEREOF | BTD, PSMB11, IAPP | PSMB5 12/4885LONP1 274/4885PSMB8 29/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.